| Year |
Citation |
Score |
| 2023 |
Traktirov DS, Nazarov IR, Artemova VS, Gainetdinov RR, Pestereva NS, Karpenko MN. Alterations in Serotonin Neurotransmission in Hyperdopaminergic Rats Lacking the Dopamine Transporter. Biomedicines. 11. PMID 38001881 DOI: 10.3390/biomedicines11112881 |
0.317 |
|
| 2023 |
Savchenko A, Targa G, Fesenko Z, Leo D, Gainetdinov RR, Sukhanov I. Dopamine Transporter Deficient Rodents: Perspectives and Limitations for Neuroscience. Biomolecules. 13. PMID 37238676 DOI: 10.3390/biom13050806 |
0.35 |
|
| 2023 |
Kozlova AA, Rubets E, Vareltzoglou MR, Jarzebska N, Ragavan VN, Chen Y, Martens-Lobenhoffer J, Bode-Böger SM, Gainetdinov RR, Rodionov RN, Bernhardt N. Knock-out of the critical nitric oxide synthase regulator DDAH1 in mice impacts amphetamine sensitivity and dopamine metabolism. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 36792833 DOI: 10.1007/s00702-023-02597-7 |
0.31 |
|
| 2023 |
Volnova A, Kurzina N, Belskaya A, Gromova A, Pelevin A, Ptukha M, Fesenko Z, Ignashchenkova A, Gainetdinov RR. Noradrenergic Modulation of Learned and Innate Behaviors in Dopamine Transporter Knockout Rats by Guanfacine. Biomedicines. 11. PMID 36672730 DOI: 10.3390/biomedicines11010222 |
0.329 |
|
| 2022 |
Nemets VV, Deal AL, Sobolev VE, Grinevich VP, Gainetdinov RR, Budygin EA. Short-Term Consequences of Single Social Defeat on Accumbal Dopamine and Behaviors in Rats. Biomolecules. 13. PMID 36671420 DOI: 10.3390/biom13010035 |
0.324 |
|
| 2022 |
Sukhanov I, Dorotenko A, Fesenko Z, Savchenko A, Efimova EV, Mor MS, Belozertseva IV, Sotnikova TD, Gainetdinov RR. Inhibition of PDE10A in a New Rat Model of Severe Dopamine Depletion Suggests New Approach to Non-Dopamine Parkinson's Disease Therapy. Biomolecules. 13. PMID 36671394 DOI: 10.3390/biom13010009 |
0.36 |
|
| 2022 |
Zhukov IS, Karpova IV, Krotova NA, Tissen IY, Demin KA, Shabanov PD, Budygin EA, Kalueff AV, Gainetdinov RR. Enhanced Aggression, Reduced Self-Grooming Behavior and Altered 5-HT Regulation in the Frontal Cortex in Mice Lacking Trace Amine-Associated Receptor 1 (TAAR1). International Journal of Molecular Sciences. 23. PMID 36430544 DOI: 10.3390/ijms232214066 |
0.308 |
|
| 2022 |
Efimova EV, Kuvarzin SR, Mor MS, Katolikova NV, Shemiakova TS, Razenkova V, Ptukha M, Kozlova AA, Murtazina RZ, Smirnova D, Veshchitskii AA, Merkulyeva NS, Volnova AB, Musienko PE, Korzhevskii DE, ... ... Gainetdinov RR, et al. Trace Amine-Associated Receptor 2 Is Expressed in the Limbic Brain Areas and Is Involved in Dopamine Regulation and Adult Neurogenesis. Frontiers in Behavioral Neuroscience. 16: 847410. PMID 35431833 DOI: 10.3389/fnbeh.2022.847410 |
0.347 |
|
| 2021 |
Sørensen G, Rickhag M, Leo D, Lycas MD, Ridderstrøm PH, Weikop P, Lilja JH, Rifes P, Herborg F, Woldbye D, Wörtwein G, Gainetdinov RR, Fink-Jensen A, Gether U. Disruption of the PDZ-domain binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis and reward motivation. The Journal of Biological Chemistry. 101361. PMID 34756883 DOI: 10.1016/j.jbc.2021.101361 |
0.363 |
|
| 2021 |
Zhukov IS, Kubarskaya LG, Karpova IV, Vaganova AN, Karpenko MN, Gainetdinov RR. Minor Changes in Erythrocyte Osmotic Fragility in Trace Amine-Associated Receptor 5 (TAAR5) Knockout Mice. International Journal of Molecular Sciences. 22. PMID 34298937 DOI: 10.3390/ijms22147307 |
0.306 |
|
| 2020 |
Sotnikova TD, Efimova EV, Gainetdinov RR. Enhanced Dopamine Transmission and Hyperactivity in the Dopamine Transporter Heterozygous Mice Lacking the D3 Dopamine Receptor. International Journal of Molecular Sciences. 21. PMID 33153031 DOI: 10.3390/ijms21218216 |
0.414 |
|
| 2020 |
Efimova EV, Kozlova AA, Razenkova V, Katolikova NV, Antonova KA, Sotnikova TD, Merkulyeva NS, Veshchitskii AS, Kalinina DS, Korzhevskii DE, Musienko PE, Kanov EV, Gainetdinov RR. Increased dopamine transmission and adult neurogenesis in trace amine-associated receptor 5 (TAAR5) knockout mice. Neuropharmacology. 182: 108373. PMID 33132188 DOI: 10.1016/j.neuropharm.2020.108373 |
0.377 |
|
| 2020 |
Kurzina NP, Aristova IY, Volnova AB, Gainetdinov RR. Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze. Behavioural Brain Research. 390: 112642. PMID 32428629 DOI: 10.1016/j.bbr.2020.112642 |
0.307 |
|
| 2019 |
Lopachev A, Volnova A, Evdokimenko A, Abaimov D, Timoshina Y, Kazanskaya R, Lopacheva O, Deal A, Budygin E, Fedorova T, Gainetdinov R. Intracerebroventricular injection of ouabain causes mania-like behavior in mice through D2 receptor activation. Scientific Reports. 9: 15627. PMID 31666560 DOI: 10.1038/S41598-019-52058-Z |
0.423 |
|
| 2019 |
Belov DR, Efimova EV, Fesenko ZS, Antonova KA, Kolodyazhny SF, Lakstygal AM, Gainetdinov RR. Putative Trace-Amine Associated Receptor 5 (TAAR5) Agonist α-NETA Increases Electrocorticogram Gamma-Rhythm in Freely Moving Rats. Cellular and Molecular Neurobiology. 40: 203-213. PMID 31385135 DOI: 10.1007/s10571-019-00716-1 |
0.32 |
|
| 2019 |
Efimova E, Katolikova N, Kozlova A, Antonova K, Murtazina R, Merkulyeva N, Veshchitskii A, Musienko P, Суханов ИМ, Espinoza S, Gainetdinov R. The role of trace amine associated receptor 5 (TAAR5) in mouse behavior and brain neurochemistry European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.09.177 |
0.332 |
|
| 2019 |
Efimova E, Gerasimov A, Sukhanov I, Korenkova O, Antonova K, Ptuha M, Volnova A, Gainetdinov R. Identification of the agonist of trace amine-associated receptor 5 (TAAR5) and its action on brain physiology and neurochemistry European Neuropsychopharmacology. 29: S571-S572. DOI: 10.1016/J.Euroneuro.2018.11.848 |
0.333 |
|
| 2019 |
Kurzina N, Volnova A, Aristova I, Gainetdinov R. Effects of dopamine level on object recognition and formation of cognitive maps in rats European Neuropsychopharmacology. 29: S139-S140. DOI: 10.1016/J.Euroneuro.2018.11.253 |
0.337 |
|
| 2018 |
Lam VM, Mielnik CA, Baimel C, Beerepoot P, Espinoza S, Sukhanov I, Horsfall W, Gainetdinov RR, Borgland SL, Ramsey AJ, Salahpour A. Behavioral Effects of a Potential Novel TAAR1 Antagonist. Frontiers in Pharmacology. 9: 953. PMID 30233365 DOI: 10.3389/Fphar.2018.00953 |
0.305 |
|
| 2018 |
Espinoza S, Leo D, Sotnikova TD, Shahid M, Kääriäinen TM, Gainetdinov RR. Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397. Frontiers in Pharmacology. 9: 645. PMID 29977204 DOI: 10.3389/fphar.2018.00645 |
0.343 |
|
| 2018 |
Meshalkina DA, Kysil EV, Antonova KA, Demin KA, Kolesnikova TO, Khatsko SL, Gainetdinov RR, Alekseeva PA, Kalueff AV. The Effects of Chronic Amitriptyline on Zebrafish Behavior and Monoamine Neurochemistry. Neurochemical Research. PMID 29740748 DOI: 10.1007/s11064-018-2536-5 |
0.324 |
|
| 2018 |
Cinque S, Zoratto F, Poleggi A, Leo D, Cerniglia L, Cimino S, Tambelli R, Alleva E, Gainetdinov RR, Laviola G, Adriani W. Behavioral Phenotyping of Dopamine Transporter Knockout Rats: Compulsive Traits, Motor Stereotypies, and Anhedonia. Frontiers in Psychiatry. 9: 43. PMID 29520239 DOI: 10.3389/Fpsyt.2018.00043 |
0.332 |
|
| 2018 |
Leo D, Sukhanov I, Zoratto F, Illiano P, Caffino L, Sanna F, Messa G, Emanuele M, Esposito A, Dorofeikova M, Budygin EA, Mus L, Efimova EE, Niello M, Espinoza S, ... ... Gainetdinov RR, et al. PRONOUNCED HYPERACTIVITY, COGNITIVE DYSFUNCTIONS AND BDNF DYSREGULATION IN DOPAMINE TRANSPORTER KNOCKOUT RATS. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29348190 DOI: 10.1523/JNEUROSCI.1931-17.2018 |
0.349 |
|
| 2016 |
Mikhailova MA, Bass CE, Grinevich VP, Chappell AM, Deal AL, Bonin KD, Weiner JL, Gainetdinov RR, Budygin EA. Optogenetically-induced tonic dopamine release from VTA-nucleus accumbens projections inhibits reward consummatory behaviors. Neuroscience. PMID 27421228 DOI: 10.1016/J.Neuroscience.2016.07.006 |
0.335 |
|
| 2016 |
Fox ME, Mikhailova MA, Bass CE, Takmakov P, Gainetdinov RR, Budygin EA, Wightman RM. Cross-hemispheric dopamine projections have functional significance. Proceedings of the National Academy of Sciences of the United States of America. PMID 27298371 DOI: 10.1073/Pnas.1603629113 |
0.334 |
|
| 2016 |
Efimova EV, Gainetdinov RR, Budygin EA, Sotnikova TD. Dopamine transporter mutant animals: a translational perspective. Journal of Neurogenetics. 30: 5-15. PMID 27276191 DOI: 10.3109/01677063.2016.1144751 |
0.364 |
|
| 2016 |
Gurevich EV, Gainetdinov RR, Gurevich VV. G protein-coupled receptor kinases as regulators of dopamine receptor functions. Pharmacological Research. PMID 27178731 DOI: 10.1016/J.Phrs.2016.05.010 |
0.342 |
|
| 2016 |
Efimova E, Leo D, Sukhanov I, Illiano P, Mus L, Espinoza S, Sotnikova T, Hoener M, Gainetdinov R. Dopamine transporter knockout rats as a novel model of dopamine associated disorders European Neuropsychopharmacology. 26: S274. DOI: 10.1016/S0924-977X(16)31160-9 |
0.337 |
|
| 2015 |
Lam VM, Espinoza S, Gerasimov AS, Gainetdinov RR, Salahpour A. In-vivo pharmacology of Trace-Amine Associated Receptor 1. European Journal of Pharmacology. PMID 26093041 DOI: 10.1016/J.Ejphar.2015.06.026 |
0.361 |
|
| 2015 |
Espinoza S, Ghisi V, Emanuele M, Leo D, Sukhanov I, Sotnikova TD, Chieregatti E, Gainetdinov RR. Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1. Neuropharmacology. 93: 308-13. PMID 25721394 DOI: 10.1016/j.neuropharm.2015.02.010 |
0.368 |
|
| 2015 |
Beaulieu JM, Espinoza S, Gainetdinov RR. Dopamine receptors - IUPHAR Review 13. British Journal of Pharmacology. 172: 1-23. PMID 25671228 DOI: 10.1111/bph.12906 |
0.365 |
|
| 2015 |
Masoud ST, Vecchio LM, Bergeron Y, Hossain MM, Nguyen LT, Bermejo MK, Kile B, Sotnikova TD, Siesser WB, Gainetdinov RR, Wightman RM, Caron MG, Richardson JR, Miller GW, Ramsey AJ, et al. Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits. Neurobiology of Disease. 74: 66-75. PMID 25447236 DOI: 10.1016/J.Nbd.2014.10.016 |
0.361 |
|
| 2014 |
Sukhanov I, Espinoza S, Yakovlev DS, Hoener MC, Sotnikova TD, Gainetdinov RR. TAAR1-dependent effects of apomorphine in mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1683-93. PMID 24925023 DOI: 10.1017/S1461145714000509 |
0.355 |
|
| 2014 |
Steinkellner T, Mus L, Eisenrauch B, Constantinescu A, Leo D, Konrad L, Rickhag M, Sørensen G, Efimova EV, Kong E, Willeit M, Sotnikova TD, Kudlacek O, Gether U, Freissmuth M, ... ... Gainetdinov RR, et al. In vivo amphetamine action is contingent on αCaMKII. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2681-93. PMID 24871545 DOI: 10.1038/Npp.2014.124 |
0.357 |
|
| 2014 |
Daigle TL, Ferris MJ, Gainetdinov RR, Sotnikova TD, Urs NM, Jones SR, Caron MG. Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2450-62. PMID 24776686 DOI: 10.1038/Npp.2014.97 |
0.395 |
|
| 2014 |
Ferris MJ, Milenkovic M, Liu S, Mielnik CA, Beerepoot P, John CE, España RA, Sotnikova TD, Gainetdinov RR, Borgland SL, Jones SR, Ramsey AJ. Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling. The European Journal of Neuroscience. 40: 2255-63. PMID 24754704 DOI: 10.1111/Ejn.12594 |
0.376 |
|
| 2014 |
Cagniard B, Sotnikova TD, Gainetdinov RR, Zhuang X. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine. Journal of Neurogenetics. 28: 112-21. PMID 24673634 DOI: 10.3109/01677063.2014.908191 |
0.343 |
|
| 2014 |
Leo D, Mus L, Espinoza S, Hoener MC, Sotnikova TD, Gainetdinov RR. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors. Neuropharmacology. 81: 283-91. PMID 24565640 DOI: 10.1016/j.neuropharm.2014.02.007 |
0.383 |
|
| 2014 |
Lavoie J, Illiano P, Sotnikova TD, Gainetdinov RR, Beaulieu JM, Hébert M. The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders. Biological Psychiatry. 75: 479-86. PMID 23305992 DOI: 10.1016/J.Biopsych.2012.11.024 |
0.306 |
|
| 2013 |
Medvedev IO, Ramsey AJ, Masoud ST, Bermejo MK, Urs N, Sotnikova TD, Beaulieu JM, Gainetdinov RR, Salahpour A. D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 18125-33. PMID 24227722 DOI: 10.1523/Jneurosci.2382-13.2013 |
0.365 |
|
| 2012 |
Managò F, Espinoza S, Salahpour A, Sotnikova TD, Caron MG, Premont RT, Gainetdinov RR. The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment. Scientific Reports. 2: 301. PMID 22393477 DOI: 10.1038/Srep00301 |
0.331 |
|
| 2012 |
Meck WH, Cheng RK, MacDonald CJ, Gainetdinov RR, Caron MG, Cevik MÖ. Gene-dose dependent effects of methamphetamine on interval timing in dopamine-transporter knockout mice. Neuropharmacology. 62: 1221-9. PMID 21296093 DOI: 10.1016/J.Neuropharm.2011.01.042 |
0.495 |
|
| 2011 |
Beaulieu JM, Del'guidice T, Sotnikova TD, Lemasson M, Gainetdinov RR. Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors. Frontiers in Molecular Neuroscience. 4: 38. PMID 22065948 DOI: 10.3389/fnmol.2011.00038 |
0.346 |
|
| 2011 |
Espinoza S, Salahpour A, Masri B, Sotnikova TD, Messa M, Barak LS, Caron MG, Gainetdinov RR. Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Molecular Pharmacology. 80: 416-25. PMID 21670104 DOI: 10.1124/Mol.111.073304 |
0.368 |
|
| 2011 |
Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R, Durkin S, Zbinden KG, Norcross R, Meyer CA, Metzler V, Chaboz S, Ozmen L, Trube G, Pouzet B, et al. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proceedings of the National Academy of Sciences of the United States of America. 108: 8485-90. PMID 21525407 DOI: 10.1073/Pnas.1103029108 |
0.373 |
|
| 2011 |
Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacological Reviews. 63: 182-217. PMID 21303898 DOI: 10.1124/pr.110.002642 |
0.346 |
|
| 2010 |
Sotnikova TD, Beaulieu JM, Espinoza S, Masri B, Zhang X, Salahpour A, Barak LS, Caron MG, Gainetdinov RR. The dopamine metabolite 3-methoxytyramine is a neuromodulator. Plos One. 5: e13452. PMID 20976142 DOI: 10.1371/Journal.Pone.0013452 |
0.392 |
|
| 2009 |
Ghisi V, Ramsey AJ, Masri B, Gainetdinov RR, Caron MG, Salahpour A. Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter. Cellular Signalling. 21: 87-94. PMID 18929645 DOI: 10.1016/J.Cellsig.2008.09.011 |
0.382 |
|
| 2008 |
Sotnikova TD, Zorina OI, Ghisi V, Caron MG, Gainetdinov RR. Trace amine associated receptor 1 and movement control. Parkinsonism & Related Disorders. 14: S99-102. PMID 18585080 DOI: 10.1016/j.parkreldis.2008.04.006 |
0.351 |
|
| 2008 |
Salahpour A, Ramsey AJ, Medvedev IO, Kile B, Sotnikova TD, Holmstrand E, Ghisi V, Nicholls PJ, Wong L, Murphy K, Sesack SR, Wightman RM, Gainetdinov RR, Caron MG. Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proceedings of the National Academy of Sciences of the United States of America. 105: 4405-10. PMID 18347339 DOI: 10.1073/Pnas.0707646105 |
0.381 |
|
| 2008 |
Gainetdinov RR. Dopamine transporter mutant mice in experimental neuropharmacology. Naunyn-Schmiedeberg's Archives of Pharmacology. 377: 301-13. PMID 18057916 DOI: 10.1007/s00210-007-0216-0 |
0.393 |
|
| 2007 |
Beaulieu JM, Gainetdinov RR, Caron MG. The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends in Pharmacological Sciences. 28: 166-72. PMID 17349698 DOI: 10.1016/j.tips.2007.02.006 |
0.313 |
|
| 2007 |
Beaulieu JM, Tirotta E, Sotnikova TD, Masri B, Salahpour A, Gainetdinov RR, Borrelli E, Caron MG. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 881-5. PMID 17251429 DOI: 10.1523/Jneurosci.5074-06.2007 |
0.32 |
|
| 2007 |
Costa RM, Gutierrez R, de Araujo IE, Coelho MR, Kloth AD, Gainetdinov RR, Caron MG, Nicolelis MA, Simon SA. Dopamine levels modulate the updating of tastant values. Genes, Brain, and Behavior. 6: 314-20. PMID 16848782 DOI: 10.1111/J.1601-183X.2006.00257.X |
0.347 |
|
| 2006 |
Caron MG, Gainetdinov RR. Dopamine: from pharmacology to molecular biology and back. Wiener Klinische Wochenschrift. 118: 565-8. PMID 17136328 DOI: 10.1007/s00508-006-0735-6 |
0.311 |
|
| 2006 |
Cyr M, Sotnikova TD, Gainetdinov RR, Caron MG. Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2541-3. PMID 17065224 DOI: 10.1096/fj.06-6533fje |
0.384 |
|
| 2006 |
Costa RM, Lin SC, Sotnikova TD, Cyr M, Gainetdinov RR, Caron MG, Nicolelis MA. Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron. 52: 359-69. PMID 17046697 DOI: 10.1016/j.neuron.2006.07.030 |
0.309 |
|
| 2006 |
Sotnikova TD, Caron MG, Gainetdinov RR. DDD mice, a novel acute mouse model of Parkinson's disease. Neurology. 67: S12-7. PMID 17030735 |
0.339 |
|
| 2006 |
Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. The Journal of Biological Chemistry. 281: 32072-80. PMID 16954211 DOI: 10.1074/jbc.M606062200 |
0.355 |
|
| 2006 |
Sasaki A, Sotnikova TD, Gainetdinov RR, Jarvis ED. Social context-dependent singing-regulated dopamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9010-4. PMID 16943558 DOI: 10.1523/JNEUROSCI.1335-06.2006 |
0.322 |
|
| 2006 |
Sotnikova TD, Beaulieu JM, Gainetdinov RR, Caron MG. Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter. Cns & Neurological Disorders Drug Targets. 5: 45-56. PMID 16613553 DOI: 10.2174/187152706784111579 |
0.34 |
|
| 2005 |
Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell. 122: 261-73. PMID 16051150 DOI: 10.1016/j.cell.2005.05.012 |
0.323 |
|
| 2005 |
Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR. Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. Plos Biology. 3: e271. PMID 16050778 DOI: 10.1371/Journal.Pbio.0030271 |
0.397 |
|
| 2004 |
Budygin EA, Brodie MS, Sotnikova TD, Mateo Y, John CE, Cyr M, Gainetdinov RR, Jones SR. Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine. Proceedings of the National Academy of Sciences of the United States of America. 101: 7781-6. PMID 15136721 DOI: 10.1073/pnas.0401418101 |
0.383 |
|
| 2004 |
Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, Caron MG. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proceedings of the National Academy of Sciences of the United States of America. 101: 5099-104. PMID 15044694 DOI: 10.1073/Pnas.0307921101 |
0.332 |
|
| 2004 |
Powell SB, Lehmann-Masten VD, Paulus MP, Gainetdinov RR, Caron MG, Geyer MA. MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice. Psychopharmacology. 173: 310-7. PMID 14747902 DOI: 10.1007/S00213-003-1765-7 |
0.322 |
|
| 2004 |
Barr AM, Lehmann-Masten V, Paulus M, Gainetdinov RR, Caron MG, Geyer MA. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 221-8. PMID 14603268 DOI: 10.1038/Sj.Npp.1300343 |
0.33 |
|
| 2003 |
Cyr M, Beaulieu JM, Laakso A, Sotnikova TD, Yao WD, Bohn LM, Gainetdinov RR, Caron MG. Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proceedings of the National Academy of Sciences of the United States of America. 100: 11035-40. PMID 12958210 DOI: 10.1073/Pnas.1831768100 |
0.341 |
|
| 2003 |
Gainetdinov RR, Bohn LM, Sotnikova TD, Cyr M, Laakso A, Macrae AD, Torres GE, Kim KM, Lefkowitz RJ, Caron MG, Premont RT. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron. 38: 291-303. PMID 12718862 DOI: 10.1016/S0896-6273(03)00192-2 |
0.369 |
|
| 2002 |
Joseph JD, Wang YM, Miles PR, Budygin EA, Picetti R, Gainetdinov RR, Caron MG, Wightman RM. Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors. Neuroscience. 112: 39-49. PMID 12044470 DOI: 10.1016/S0306-4522(02)00067-2 |
0.389 |
|
| 2002 |
Raevskii KS, Gainetdinov RR, Budygin EA, Mannisto P, Wightman M. Dopaminergic transmission in the rat striatum in vivo in conditions of pharmacological modulation. Neuroscience and Behavioral Physiology. 32: 183-8. PMID 11942697 DOI: 10.1023/A:1013931609942 |
0.361 |
|
| 2001 |
Miller GW, Wang YM, Gainetdinov RR, Caron MG. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease. Methods in Molecular Medicine. 62: 179-90. PMID 21318776 DOI: 10.1385/1-59259-142-6:179 |
0.318 |
|
| 2001 |
Gainetdinov RR, Mohn AR, Bohn LM, Caron MG. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proceedings of the National Academy of Sciences of the United States of America. 98: 11047-54. PMID 11572967 DOI: 10.1073/Pnas.191353298 |
0.418 |
|
| 2001 |
Sotnikova TD, Gainetdinov RR, Grekhova TV, Rayevsky KS. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study) Pharmacological Research. 43: 283-290. PMID 11401421 DOI: 10.1006/phrs.2000.0773 |
0.353 |
|
| 2001 |
Budygin EA, Phillips PE, Robinson DL, Kennedy AP, Gainetdinov RR, Wightman RM. Effect of acute ethanol on striatal dopamine neurotransmission in ambulatory rats. The Journal of Pharmacology and Experimental Therapeutics. 297: 27-34. PMID 11259524 |
0.317 |
|
| 2001 |
Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG, Hen R. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proceedings of the National Academy of Sciences of the United States of America. 98: 1982-7. PMID 11172062 DOI: 10.1073/pnas.98.4.1982 |
0.398 |
|
| 2000 |
Walker JKL, Gainetdinov RR, Mangel AW, Caron MG, Shetzline MA. Mice lacking the dopamine transporter display altered regulation of distal colonic motility American Journal of Physiology - Gastrointestinal and Liver Physiology. 279: G311-G318. PMID 10915639 |
0.343 |
|
| 2000 |
Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM, Caron MG. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nature Neuroscience. 3: 465-71. PMID 10769386 DOI: 10.1038/74839 |
0.357 |
|
| 1999 |
Huotari M, Gainetdinov R, Männistö PT. Microdialysis studies on the action of tolcapone on pharmacologically- elevated extracellular dopamine levels in conscious rats Pharmacology and Toxicology. 85: 233-238. PMID 10608486 DOI: 10.1111/J.1600-0773.1999.Tb02014.X |
0.42 |
|
| 1999 |
Jones SR, Gainetdinov RR, Caron MG. Application of microdialysis and voltammetry to assess dopamine functions in genetically altered mice: correlation with locomotor activity. Psychopharmacology. 147: 30-2. PMID 10591864 DOI: 10.1007/s002130051137 |
0.318 |
|
| 1999 |
Miller GW, Gainetdinov RR, Levey AI, Caron MG. Dopamine transporters and neuronal injury. Trends in Pharmacological Sciences. 20: 424-9. PMID 10498956 DOI: 10.1016/S0165-6147(99)01379-6 |
0.331 |
|
| 1999 |
Gainetdinov RR, Jones SR, Caron MG. Functional hyperdopaminergia in dopamine transporter knock-out mice. Biological Psychiatry. 46: 303-11. PMID 10435196 DOI: 10.1016/S0006-3223(99)00122-5 |
0.385 |
|
| 1999 |
Jones SR, Gainetdinov RR, Hu XT, Cooper DC, Wightman RM, White FJ, Caron MG. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nature Neuroscience. 2: 649-55. PMID 10404198 DOI: 10.1038/10204 |
0.395 |
|
| 1999 |
Budygin EA, Gainetdinov RR, Kilpatrick MR, Rayevsky KS, Männistö PT, Wightman RM. Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake. European Journal of Pharmacology. 370: 125-31. PMID 10323260 DOI: 10.1016/S0014-2999(99)00084-9 |
0.357 |
|
| 1999 |
Fumagalli F, Gainetdinov RR, Wang YM, Valenzano KJ, Miller GW, Caron MG. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2424-31. PMID 10087057 DOI: 10.1523/Jneurosci.19-07-02424.1999 |
0.365 |
|
| 1999 |
Melnikova V, Orosco M, Calas A, Sapronova A, Gainetdinov R, Delhaye-Bouchaud N, Nicolaidis S, Rayevsky K, Ugrumov M. Dopamine turnover in the mediobasal hypothalamus in rat fetuses. Neuroscience. 89: 235-41. PMID 10051232 DOI: 10.1016/S0306-4522(98)00278-4 |
0.399 |
|
| 1999 |
Gainetdinov RR. DOPAMINE AND NOREPINEPHRINE TRANSPORTER MUTANT MICE AND COCAINE DEPENDENCE Behavioural Pharmacology. 10: S36. DOI: 10.1097/00008877-199908001-00090 |
0.32 |
|
| 1999 |
Budygin EA, Kilpatrick M, Gainetdinov RR, Rayevsky KS, Wightman RM. The effect of the dopamine re-uptake inhibitor GBR 12909 on dopaminergic neurotransmission in rat striatum in vivo Eksperimental'Naya I Klinicheskaya Farmakologiya. 62: 5-6. |
0.325 |
|
| 1998 |
Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG. Cocaine self-administration in dopamine-transporter knockout mice. Nature Neuroscience. 1: 132-7. PMID 10195128 DOI: 10.1038/381 |
0.31 |
|
| 1998 |
Gainetdinov RR, Jones SR, Fumagalli F, Wightman RM, Caron MG. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Research. Brain Research Reviews. 26: 148-53. PMID 9651511 DOI: 10.1016/S0165-0173(97)00063-5 |
0.364 |
|
| 1998 |
Fumagalli F, Gainetdinov RR, Valenzano KJ, Caron MG. Role of dopamine transporter in methamphetamine-induced neurotoxicity: Evidence from mice lacking the transporter Journal of Neuroscience. 18: 4861-4869. PMID 9634552 |
0.342 |
|
| 1998 |
Gainetdinov RR, Fumagalli F, Wang YM, Jones SR, Levey AI, Miller GW, Caron MG. Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice. Journal of Neurochemistry. 70: 1973-8. PMID 9572281 DOI: 10.1046/J.1471-4159.1998.70051973.X |
0.313 |
|
| 1998 |
Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proceedings of the National Academy of Sciences of the United States of America. 95: 4029-34. PMID 9520487 DOI: 10.1073/Pnas.95.7.4029 |
0.385 |
|
| 1998 |
Jones SR, Gainetdinov RR, Wightman RM, Caron MG. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 1979-86. PMID 9482784 DOI: 10.1523/Jneurosci.18-06-01979.1998 |
0.343 |
|
| 1998 |
Gainetdinov RR, Jones SR, Wightman RM, Carona MG. HYPERDOPAMINERGIC PHENOTYPE OF DOPAMINE TRANSPORTER KNOCKOUT MICE Behavioural Pharmacology. 9: S39. DOI: 10.1097/00008877-199808000-00075 |
0.353 |
|
| 1998 |
Rocha B, Fumagalli F, Gainetdinov R, Jones S, Ator R, Giros B, Miller G, Caron M. Erratum: Cocaine self-administration in dopamine-transporter knockout mice Nature Neuroscience. 1: 330-330. DOI: 10.1038/1152 |
0.371 |
|
| 1997 |
Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS. Effects of a psychostimulant drug sydnocarb on rat brain dopaminergic transmission in vivo European Journal of Pharmacology. 340: 53-58. PMID 9527506 DOI: 10.1016/S0014-2999(97)01407-6 |
0.332 |
|
| 1997 |
Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron. 19: 1285-96. PMID 9427251 DOI: 10.1016/S0896-6273(00)80419-5 |
0.371 |
|
| 1997 |
Gainetdinov RR, Fumagalli F, Jones SR, Caron MG. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. Journal of Neurochemistry. 69: 1322-5. PMID 9282960 DOI: 10.1046/J.1471-4159.1997.69031322.X |
0.347 |
|
| 1997 |
Bossé R, Fumagalli F, Jaber M, Giros B, Gainetdinov RR, Wetsel WC, Missale C, Caron MG. Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron. 19: 127-38. PMID 9247269 DOI: 10.1016/S0896-6273(00)80353-0 |
0.325 |
|
| 1997 |
Rayevsky K, Kudrin V, Ganiev M, Gainetdinov R, Sotnikova T. P.2.086 Typical and atypical antipsychotics differ by their relation to various subtypes of brain dopamine receptor European Neuropsychopharmacology. 7: S219. DOI: 10.1016/S0924-977X(97)88720-2 |
0.329 |
|
| 1997 |
Rayevsky K, Sotnikova T, Gainetdinov R. Atypical antipsychotics affect prefferentially dopamine but not dopac extracellular levels in rat dorsal striatum Biological Psychiatry. 42: 174S. DOI: 10.1016/S0006-3223(97)87614-7 |
0.316 |
|
| 1997 |
Budygin EA, Gainetdinov RR, Raevsky KS, Li IH, Mannisto PT. Microdialysis of the effect of tolcapone in GBR-12909-induced blockade of dopamine uptake Eksperimental'Naya I Klinicheskaya Farmakologiya. 60: 10. |
0.333 |
|
| 1997 |
Rayevsky KS, Gainetdinov RR, Sotnikova TD. Functional heterogeneity of brain dopamine recetors and effects of old and new antipsychotics Faseb Journal. 11: A212. |
0.317 |
|
| 1996 |
Raevskii KS, Sotnikova TD, Gainetdinov RR. The brain dopaminergic systems: receptor heterogeneity, functional role and pharmacological regulation | Dofaminergicheskie sistemy mozga: retseptornaia geterogennost', funktsional'naia rol', farmakologicheskaia reguliatsiia Uspekhi Fiziologicheskikh Nauk. 27: 3-29. PMID 9019922 |
0.329 |
|
| 1996 |
Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis European Journal of Pharmacology. 308: 261-269. PMID 8858296 DOI: 10.1016/0014-2999(96)00300-7 |
0.343 |
|
| 1996 |
Sotnikova TD, Gainetdinov RR, Grekhova TV, Raevskii KS. Dopamine autoreceptors subtype D3 predominantly regulate the liberation of dopamine in rat brain basal ganglia | Dofaminovye autoretseptory D3 podtipa preimushchestvenno reguliruiut vysvobozhdenie dofamina v bazal'nykh gangliiakh mozga krys Biulleten' Eksperimental'Noi Biologii I Meditsiny. 121: 430-434. PMID 8829459 |
0.31 |
|
| 1996 |
Gainetdinov RR, Raevskii KS. Substances increasing the extracellular content of dopamine in the striatum prevent the development of haloperidol catalepsy in rats Bulletin of Experimental Biology and Medicine. 121: 399-401. |
0.31 |
|
| 1996 |
Sotnikova TD, Gainetdinov RR, Grekhova TV, Raevskii KS. Dopamine autoreceptors of subtype D3 regulate mainly dopamine release in the basal ganglia of rat brain Bulletin of Experimental Biology and Medicine. 121: 392-396. |
0.34 |
|
| 1995 |
Rayevsky KS, Gainetdinov RR, Grekhova TV, Sotnikova TD. Regulation of dopamine release and metabolism in rat striatum in vivo: Effects of dopamine receptor antagonists Progress in Neuropsychopharmacology and Biological Psychiatry. 19: 1285-1303. PMID 8868210 DOI: 10.1016/0278-5846(95)00267-7 |
0.332 |
|
| 1995 |
Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS. Preferential role of D3 dopamine autoreceptor in regulation of dopamine release but not synthesis in nucleus accumbens and dorsal striatum of freely moving rats Behavioural Pharmacology. 6: 74. DOI: 10.1097/00008877-199505001-00088 |
0.318 |
|
| 1994 |
Gainetdinov RR, Grekhova TV, Sotnikova TD, Rayevsky KS. Dopamine D2 and D3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats European Journal of Pharmacology. 261: 327-331. PMID 7813556 DOI: 10.1016/0014-2999(94)90125-2 |
0.345 |
|
| Show low-probability matches. |